Catalyst Pharmaceuticals (CPRX)
2.75
+0.13 +4.96%
NASDAQ
Oct 20, 16:59
Delayed 2m
USD
View All Key Stats
CPRX Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.21 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -16.96M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 232.53M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 6.845 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -3.201M |
| Return on Equity (TTM) | -- |
View All CPRX News
CPRX News
-
WireHeadlineTime (ET)
-
Globe Newswire10/16 08:03
-
PR Newswire10/10 06:20
-
PR Newswire09/05 06:20
-
MT Newswires08/30 09:33
-
Globe Newswire08/30 08:03
-
Yahoo08/30 08:03
-
PR Newswire08/17 11:00
-
Yahoo08/10 06:40
-
Yahoo08/09 22:00
-
MT Newswires08/09 17:57
View All Events
CPRX Events
| Date | Type | Description |
|---|---|---|
| 08/10/2018 | Misc | Catalyst Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2018 |
| 08/09/2018 | Earnings | Catalyst Pharmaceuticals Inc Second Quarter Earnings Results in 2018 |
| 05/25/2018 | Misc | Catalyst Pharmaceuticals Inc Annual General Meeting in 2017 |
| 05/11/2018 | Misc | Catalyst Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018 |
| 05/10/2018 | Earnings | Catalyst Pharmaceuticals Inc First Quarter Earnings Results in 2018 |
| 03/16/2018 | Misc | Catalyst Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2017 |
| 03/15/2018 | Earnings | Catalyst Pharmaceuticals Inc Fourth Quarter Earnings Results in 2017 |
| 11/10/2017 | Misc | Catalyst Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2017 |
| 11/10/2017 | Earnings | Catalyst Pharmaceuticals Inc Third Quarter Earnings Results in 2017 |
| 08/10/2017 08:30 EDT | Misc | Catalyst Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2017 |
CPRX Fundamentals
Income Statement View Statement
CPRX Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
CPRX One Page Reports
- One Page Report Download
CPRX Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 2.75 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.catalystpharma.com
- Investor Relations URL: http://ir.catalystpharma.com/
- HQ State/Province: Florida
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Small Cap/Blend
- Next Earnings Release: Nov. 10, 2017
- Last Earnings Release: Aug. 09, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Catalyst Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for people with rare debilitating diseases.
CPRX Comparables
EditCPRX Excel Add-In Codes
- Name: =YCI("CPRX","name")
- Description: =YCI("CPRX","description")
- Sector: =YCI("CPRX","sector")
- Industry: =YCI("CPRX","industry")
- Est. Current Fiscal Year End: =YCI("CPRX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other CPRX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CPRX Tweets Stocktwits
Advertisement
